Cochrane Abstracts
Histamine type 2 receptor antagonists as adjuvant treatment for resected colorectal cancer
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Histamine Type 2 Receptor Antagonists as Adjuvant Treatment for Resected Colorectal Cancer." Cochrane Abstracts, John Wiley & Sons, Inc, 2024. Evidence Central, evidence.unboundmedicine.com/evidence/view/Cochrane/432988/all/Histamine_type_2_receptor_antagonists_as_adjuvant_treatment_for_resected_colorectal_cancer:_Cochrane_systematic_review.
Histamine type 2 receptor antagonists as adjuvant treatment for resected colorectal cancer. Cochrane Abstracts. John Wiley & Sons, Inc; 2024. https://evidence.unboundmedicine.com/evidence/view/Cochrane/432988/all/Histamine_type_2_receptor_antagonists_as_adjuvant_treatment_for_resected_colorectal_cancer:_Cochrane_systematic_review. Accessed December 12, 2024.
Histamine type 2 receptor antagonists as adjuvant treatment for resected colorectal cancer. (2024). In Cochrane Abstracts. John Wiley & Sons, Inc. https://evidence.unboundmedicine.com/evidence/view/Cochrane/432988/all/Histamine_type_2_receptor_antagonists_as_adjuvant_treatment_for_resected_colorectal_cancer:_Cochrane_systematic_review
Histamine Type 2 Receptor Antagonists as Adjuvant Treatment for Resected Colorectal Cancer [Internet]. In: Cochrane Abstracts. John Wiley & Sons, Inc; 2024. [cited 2024 December 12]. Available from: https://evidence.unboundmedicine.com/evidence/view/Cochrane/432988/all/Histamine_type_2_receptor_antagonists_as_adjuvant_treatment_for_resected_colorectal_cancer:_Cochrane_systematic_review.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Histamine type 2 receptor antagonists as adjuvant treatment for resected colorectal cancer
ID - 432988
BT - Cochrane Abstracts
UR - https://evidence.unboundmedicine.com/evidence/view/Cochrane/432988/all/Histamine_type_2_receptor_antagonists_as_adjuvant_treatment_for_resected_colorectal_cancer:_Cochrane_systematic_review
PB - John Wiley & Sons, Inc
DB - Evidence Central
DP - Unbound Medicine
ER -
